Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Guidance for Elderly With Cognitive Disorders (BOCS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by University Hospital, Ghent
Information provided by (Responsible Party):
University Hospital, Ghent Identifier:
First received: February 25, 2010
Last updated: June 2, 2015
Last verified: June 2015
The purpose of the programme is to facilitate the anticipation of dementia both in elderly patients suffering from this disease and in their carers and to diminish care burden in order to improve quality of life and daily functioning.

Mild Dementia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Guidance Programme for Elderly With Cognitive Disorders

Resource links provided by NLM:

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Quality of life and care burden at 0, 3 and 6 months. [ Time Frame: 0, 3 and 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cognitive, behavioural and affective status [ Time Frame: 0, 3 and 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2010
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Elderly with mild dementia
>70 years old and presence of a carer


Ages Eligible for Study:   70 Years and older   (Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
elderly (>70 years) with mild dementia in presence of a carer.

Inclusion Criteria:

  • elderly (> 70 years) with mild dementia in presence of a carer.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01076855

Contact: Mirko Petrovic, MD, PhD
Contact: Carine Sachem

University Hospital Ghent Recruiting
Ghent, Belgium
Contact: Mirko Petrovic, MD, PhD   
Principal Investigator: Mirko Petrovic, MD, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Mirko Petrovic, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: University Hospital, Ghent Identifier: NCT01076855     History of Changes
Other Study ID Numbers: 2010/008 
Study First Received: February 25, 2010
Last Updated: June 2, 2015
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Cognition Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders processed this record on October 21, 2016